project	sample	experiment	run	read_count_as_reported_by_sra	reads_downloaded	proportion_of_reads_reported_by_sra_downloaded	paired_end	sra_misreported_paired_end	mapped_read_count	auc	sharq_beta_tissue	sharq_beta_cell_type	biosample_submission_date	biosample_publication_date	biosample_update_date	avg_read_length	geo_accession	bigwig_file	title	characteristics
SRP048700	SRS717384	SRX726603	SRR1604987	93280442	93280442	1	TRUE	FALSE	89098296	8505663433	NA	NA	2014-10-07T09:45:13.120	2014-10-08T00:44:10.117	2014-10-08T01:22:53.687	200	GSM1519974	SRR1604987.bw	Vehicle-treated HCC827	c("cell line: NSCLC cell line HCC827", "treatment: ClonTracer-barcoded HCC827 cell population was treated with 0.1% DMSO for 4 days.", "resistant to: Vehicle control - Treated with 0.1% DMSO")
SRP048700	SRS717384	SRX726603	SRR1604988	97971400	97971400	1	TRUE	FALSE	93530605	8952353980	NA	NA	2014-10-07T09:45:13.120	2014-10-08T00:44:10.117	2014-10-08T01:22:53.687	200	GSM1519974	SRR1604988.bw	Vehicle-treated HCC827	c("cell line: NSCLC cell line HCC827", "treatment: ClonTracer-barcoded HCC827 cell population was treated with 0.1% DMSO for 4 days.", "resistant to: Vehicle control - Treated with 0.1% DMSO")
SRP048700	SRS717385	SRX726604	SRR1604989	64938412	64938412	1	TRUE	FALSE	64337459	6319479734	NA	NA	2014-10-07T09:45:15.117	2014-10-08T00:44:10.200	2014-10-08T01:22:54.243	200	GSM1519975	SRR1604989.bw	Erlotinib-resistant HCC827	c("cell line: NSCLC cell line HCC827", "treatment: ClonTracer-barcoded HCC827 cell population was treated with 2 µM erlotinib for 47 days to generate the erlotinib-resistant cell population.", "resistant to: 2 µM erlotinib")
SRP048700	SRS717385	SRX726604	SRR1604990	65241040	65241040	1	TRUE	FALSE	64654966	6351586972	NA	NA	2014-10-07T09:45:15.117	2014-10-08T00:44:10.200	2014-10-08T01:22:54.243	200	GSM1519975	SRR1604990.bw	Erlotinib-resistant HCC827	c("cell line: NSCLC cell line HCC827", "treatment: ClonTracer-barcoded HCC827 cell population was treated with 2 µM erlotinib for 47 days to generate the erlotinib-resistant cell population.", "resistant to: 2 µM erlotinib")
SRP048700	SRS717386	SRX726605	SRR1604991	53617918	53617918	1	TRUE	FALSE	53276333	5233540157	NA	NA	2014-10-07T09:45:17.407	2014-10-08T00:44:10.220	2014-10-08T01:22:54.700	200	GSM1519976	SRR1604991.bw	Erlotinib/crizotinib dual resistant HCC827	c("cell line: NSCLC cell line HCC827", "treatment: The erlotinib-resistant HCC827 cell population was treated with 2 µM erlotinib+0.2 µM crizotinib combination for 10 days to enrich for erlotinib/crizotinib dual-resistant subpopulations.", "resistant to: 2 µM erlotinib+0.2 µM crizotinib combination")
SRP048700	SRS717386	SRX726605	SRR1604992	53670950	53670950	1	TRUE	FALSE	53341501	5241043453	NA	NA	2014-10-07T09:45:17.407	2014-10-08T00:44:10.220	2014-10-08T01:22:54.700	200	GSM1519976	SRR1604992.bw	Erlotinib/crizotinib dual resistant HCC827	c("cell line: NSCLC cell line HCC827", "treatment: The erlotinib-resistant HCC827 cell population was treated with 2 µM erlotinib+0.2 µM crizotinib combination for 10 days to enrich for erlotinib/crizotinib dual-resistant subpopulations.", "resistant to: 2 µM erlotinib+0.2 µM crizotinib combination")